It will be informative to determine the feasibility and efficacy of this heterogenous suture MSC population in treating craniosynostosis, including Axin2+, Prrx1+, Ctsk+ and CD51+;CD200+ cells. The gene discussed is PRRX1; the disease is craniosynostosis.